Anish K. Vadukoot

Synthesis and SAR Studies of 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors

Anish K. Vadukoot, Swagat Sharma, Christopher D. Aretz et al. · ACS Medicinal Chemistry Letters · 2020 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Design of a hydrogen peroxide-activatable agent that specifically targets cancer cells

Anish K. Vadukoot, Safnas F. AbdulSalam, Mark Wunderlich et al. · Bioorganic & Medicinal Chemistry · 2014 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +14

Discovery and Characterization of 1<i>H</i>-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators

Joshua M. Wieting, Anish K. Vadukoot, Swagat Sharma et al. · ACS Chemical Neuroscience · 2017 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

KVA-D-88, a Novel Preferable Phosphodiesterase 4B Inhibitor, Decreases Cocaine-Mediated Reward Properties <i>in Vivo</i>

Maria Burkovetskaya, Qiaoling Liu, Anish K. Vadukoot et al. · ACS Chemical Neuroscience · 2020 · 16 citations · Full text

Medicine, Neuroscience, Pharmacology +16

Novel ROS-activated agents utilize a tethered amine to selectively target acute myeloid leukemia

Tiffany R. Bell‐Horwath, Anish K. Vadukoot, Fathima Shazna Thowfeik et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15